Mark Adams, Ph.D., leads the clinical and research genomics services that provide access to next-generation sequencing platforms for JAX researchers. The CAP-accredited Advanced Precision Medicine Laboratory offers genetic testing to patients in the context of cancer and rare diseases.
Adams was a co-founder of The Institute for Genomic Research and Celera Genomics where he led the DNA sequencing and genome annotation groups responsible for sequencing of the initial human, mouse, and Drosophila genomes. He then joined the Department of Genetics at Case Western Reserve University, where he was an associate professor. Prior to joining JAX, he was the scientific director and professor at the J. Craig Venter Institute where he directed programs that characterized genomic changes in the evolution of antibiotic resistance in hospital-acquired infections.
He has a BA in Chemistry from Warren Wilson College and a Ph.D. in Biological Chemistry from the University of Michigan.
